get a key
steadybase-$ company SCYX
account_id none on file
legal_name Scynexis Inc
ticker SCYX
cik 1178253
domain scynexis.com
entry_point_account_id none on file
name SCYNEXIS Inc.
exchange Nasdaq
sector Health Care
hq Jersey City, NJ, United States
calls 1 filings 2 executives 2 family 0
why_nownone on file
calls
Yes, you're right. You expect those lines to kind of travel together, so prescription utilization and covered lives traveling together, because obviously when a doctor chooses BrexFM for his or her patients, and you generate more coverage for those patients, you start to see increases in both of those lines. They travel together.

Nov 10, 2021 / receipt, needs a key / Kumar Raja, other | earnings call 2021-11-10 | transcript 65071134-a391-4446-80e2-608f32f09d9e | chars 29477-29808 | segment 30

filings
Mr. Macleod ceased serving as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer effective September 9, 2026.

filing / Sep 10, 2026 / receipt

On September 10, 2026, the Company announced that Sanjay Subramanian, MBA, has been appointed to serve as SCYNEXIS’s Chief Financial Officer, in which role he will be SCYNEXIS’s principal financial officer and principal accounting officer.

filing / Sep 10, 2026 / receipt

executives
Christine Coyne Chief Commercial Officer - receipt
Dr. Marco Taglietti President and CEO - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2015-02-11 Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$